benzeneboronic acid has been researched along with Breast Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, X; Li, X; Liu, L; Wang, Y; Wei, X; Zhao, J; Zhou, S | 1 |
| Chen, X; He, X; Liu, C; Liu, H; Liu, P; Ma, D; Tang, Q; Ye, L; Zhao, X; Zou, H | 1 |
| Furusho, H; Horiguchi, Y; Kurosu, K; Nagasaki, Y; Shashni, B | 1 |
| Djermic, D; Galic, B; Ivankovic, S; Marasovic, M; Milos, M; Stojkovic, R | 1 |
| Chatterjee, S; Das, J; Ghosh, N; Kundu, M; Manna, P; Sadhukhan, P; Sil, PC | 1 |
| Bae, YH; Chen, L; Fan, B; Gao, Z; Huang, W; Jin, M; Kang, L; Sun, P; Wang, Q | 1 |
6 other study(ies) available for benzeneboronic acid and Breast Neoplasms
| Article | Year |
|---|---|
Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Boronic Acids; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Delayed-Action Preparations; Doxorubicin; Drug Carriers; Drug Therapy, Combination; Female; Humans; Imiquimod; Immunologic Factors; Immunotherapy; Macrophages; Mice; Mice, Inbred BALB C; Micelles; Neoplasms, Experimental; Polyesters; Polyethylene Glycols; Polymers; Toll-Like Receptor 7; Tumor Microenvironment | 2019 |
Nanoassemblies with Effective Serum Tolerance Capability Achieving Robust Gene Silencing Efficacy for Breast Cancer Gene Therapy.
Topics: Animals; Boronic Acids; Breast Neoplasms; Cations; Cell Line, Tumor; Cell Membrane Permeability; Dendrimers; Drug Tolerance; Female; Gene Silencing; Genes, erbB-1; Genetic Therapy; Humans; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Polyamines; Polyethylene Glycols; RNA, Small Interfering; Serum; Time Factors; Transfection | 2021 |
Application of surface enhanced Raman spectroscopy as a diagnostic system for hypersialylated metastatic cancers.
Topics: Animals; Blotting, Western; Boronic Acids; Breast Neoplasms; Cell Line, Tumor; Chromatography, Gel; Gold; Humans; MCF-7 Cells; Metal Nanoparticles; Mice; N-Acetylneuraminic Acid; NF-kappa B; Reactive Oxygen Species; Spectrum Analysis, Raman | 2017 |
In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Boronic Acids; Breast Neoplasms; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cricetinae; Female; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C | 2017 |
Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy.
Topics: Animals; Apoptosis; Boronic Acids; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Liberation; Female; Humans; Hydrogen-Ion Concentration; Membrane Potential, Mitochondrial; Metal Nanoparticles; Mice; Quercetin; Reactive Oxygen Species; Transplantation, Heterologous; Zinc Oxide | 2019 |
Systemic siRNA Delivery with a Dual pH-Responsive and Tumor-targeted Nanovector for Inhibiting Tumor Growth and Spontaneous Metastasis in Orthotopic Murine Model of Breast Carcinoma.
Topics: Administration, Intravenous; Animals; Antineoplastic Agents; Biological Products; Boronic Acids; Breast Neoplasms; Disease Models, Animal; Gene Silencing; Hydrogen-Ion Concentration; Mice; Molecular Targeted Therapy; Nanoparticles; Neoplasm Metastasis; Polyethylene Glycols; RNA, Small Interfering | 2017 |